Digital Breast Tomosynthesis Spurring Mammography Equipment Market Growth

This research report primarily based on the Digital Breast Tomosynthesis (DBT) Equipment market and covers Market Study Report includes current and upcoming industry trends further to the global spectrum of the Digital Breast Tomosynthesis (DBT) Equipment market that includes distinct regions. Likewise, the report additionally expands on elaborate information concerning contributions by way of key vendors, demand, and deliver evaluation as well as market proportion boom of the Digital Breast Tomosynthesis (DBT) Equipment industry.

Digital breast tomosynthesis (DBT) or 3-D mammography new installations (includes new equipment and 3-D upgradation) expected to reach 4,547 units in 2016, up from 4,061 units in 2015. In terms of revenues, the global digital breast tomosynthesis equipment market is expected to reach 1,007.6 Mn in 2016, witnessing a year-over-year growth of 13.7%. 

To remain ‘ahead’ of your competitors, request for a sample>>> https://www.futuremarketinsights.com/reports/sample/rep-gb-1241

Limitations concerning the flat nature of images achieved through a 2-D full-field digital mammography (FFDM) is influencing end-users to adopt DBT equipment for diagnosis of breast cancers. Digital breast tomosynthesis enables radiologists to analyse abnormalities lucidly, helping improve detection rates while reducing callbacks. In the backdrop of these factors, demand for digital breast tomosynthesis equipment is witnessing an uptick, and the trend is expected to gain further momentum in the future.

Sales of DBTs have remained quite robust in the US in the recent past, making North America the most lucrative market globally. The market in the region is largely dominated by Hologic, Inc. although GE and Siemens Healthineers have also registered their presence by launching innovative DBT products at competitive prices. Total DBT equipment revenues in North America were pegged at 472.8 Mn in 2015, with the U.S. accounting for bulk of revenue share. New equipment installation base in North America is expected to reach 2,327 in 2016, up from 2,066 in 2015.

In addition to North America, digital breast tomosynthesis sales are also growing steadily in Western Europe and APEJ. Revenues in Western Europe are anticipated to grow by 13.4% in 2016, whereas APEJ is expected to increase at 12.2%.

By end-users, hospitals account for higher demand for DBTs vis-à-vis diagnostic centres. Many hospitals are in the process of upgrading their existing mammography machines, owing to which demand for DBT equipment is growing at a steady rate. However, high costs, coupled with lack of awareness can impede adoption rates in both hospitals and diagnostic centres, and slow down the growth of the market globally. Installations of DBTs in hospitals totalled 3,020 in 2015, representing a market value worth 542.8 Mn.

Key players in the global digital breast tomosynthesis equipment market include Hologic Inc., GE Healthcare, Siemens Healthineers, Internazionale Medico Scientifica, Fujifilm, and Planmed Oy. The top 3 players – Hologic, Inc., GE Healthcare, and Siemens Healthineers collectively account for nearly 90% revenue share of the market.

Long-term Outlook: In terms of revenues, the global tomosynthesis equipment market is expected to increase at 13.9% CAGR during the forecast period 2016-2026. Total installations of DBT equipment are anticipated to reach 17,700 units.

Get Access to Research Methodology Prepared by Experts>>> https://www.futuremarketinsights.com/ask-question/rep-gb-1241

Key Segments Covered

By Product type

• DBT Equipment
• 3-D Upgradation

By End User

• Hospital
• Diagnostic centres

Key Regions Covered

• North America
• Latin America
• Western Europe
• Eastern Europe
• APEJ
• Japan
• MEA

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/1241

More from Healthcare, Pharmaceuticals and Medical devices: 

• Genital Herpes Treatment Market Segmentation By Drug Type – Acyclovir, Valacyclovir, Famciclovir; By Distribution Channel Type – Hospital Pharmacies,Retail Pharmacies,Online Pharmacies, Drug Stores; By Route of Administration Type – Oral, Topical, Injectable; By Indication Type – HSV-1,HSV-2
• Exosome Diagnostic and Therapeutics Market Segmentation By Product Type – Instrument, Software, Reagents and, Kits; By Application Type – Diagnostics,Therapeutics; By End User Type – Hospitals,Cancer Institutes,Diagnostic Centres,Others
• Anaesthesia Machines Market Segmentation By Modality Type – Standalone Anaesthesia Machines, Portable Anaesthesia Machines; By End User Type – Hospitals, Surgical Ambulatory Centres, Clinics,Nursing Facilities

About Us

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Contact:
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com